Harel Insurance Investments & Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$597K Buy
1,138
+495
+77% +$260K 0.01% 204
2025
Q1
$408K Buy
643
+8
+1% +$5.08K 0.01% 223
2024
Q4
$452K Sell
635
-24
-4% -$17.1K 0.01% 157
2024
Q3
$693K Buy
659
+266
+68% +$280K 0.01% 156
2024
Q2
$413K Sell
393
-289
-42% -$304K 0.01% 193
2024
Q1
$656K Buy
682
+362
+113% +$348K 0.01% 154
2023
Q4
$281K Sell
320
-403
-56% -$354K ﹤0.01% 250
2023
Q3
$598K Buy
723
+372
+106% +$308K 0.01% 180
2023
Q2
$252K Sell
351
-3,294
-90% -$2.36M 0.01% 286
2023
Q1
$2.96M Sell
3,645
-2,338
-39% -$1.9M 0.06% 116
2022
Q4
$4.3M Buy
5,983
+3,268
+120% +$2.35M 0.09% 95
2022
Q3
$1.88M Buy
2,715
+764
+39% +$528K 0.05% 139
2022
Q2
$1.15M Buy
1,951
+1,891
+3,152% +$1.12M 0.02% 176
2022
Q1
$42K Sell
60
-2,418
-98% -$1.69M ﹤0.01% 536
2021
Q4
$1.59M Buy
2,478
+2,106
+566% +$1.35M 0.03% 139
2021
Q3
$225K Sell
372
-1,861
-83% -$1.13M 0.01% 356
2021
Q2
$4.07M Buy
2,233
+1,107
+98% +$2.02M 0.09% 112
2021
Q1
$1.78M Sell
1,126
-512
-31% -$809K 0.03% 262
2020
Q4
$2.37M Buy
1,638
+131
+9% +$189K 0.06% 162
2020
Q3
$844K Buy
+1,507
New +$844K 0.03% 139
2020
Q2
Sell
-643
Closed -$314K 570
2020
Q1
$314K Buy
643
+207
+47% +$101K 0.01% 136
2019
Q4
$164K Buy
436
+293
+205% +$110K 0.01% 222
2019
Q3
$39K Hold
143
﹤0.01% 326
2019
Q2
$45K Buy
143
+73
+104% +$23K ﹤0.01% 326
2019
Q1
$29K Buy
+70
New +$29K ﹤0.01% 326
2017
Q1
Sell
-2
Closed -$1K 472
2016
Q4
$1K Sell
2
-80
-98% -$40K ﹤0.01% 364
2016
Q3
$33K Hold
82
﹤0.01% 254
2016
Q2
$29K Buy
82
+2
+3% +$707 ﹤0.01% 413
2016
Q1
$29K Sell
80
-60
-43% -$21.8K ﹤0.01% 247
2015
Q4
$76K Buy
+140
New +$76K 0.01% 170